Wachiwit/iStock Editorial via Getty Images
Johnson & Johnson (JNJ) up 1.4% post-market Monday after saying it agreed to pay up to $5.5B to settle remaining lawsuits that alleged its talc products caused ovarian cancer.
The company said it reached an agreement for a comprehensive resolution
